A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC).
Lalezari
J P
JP
UCSF, USA.
Stagg
R J
RJ
Jaffe
H S
HS
Hitchcock
M J
MJ
Drew
W L
WL
D000818:Animals; D000998:Antiviral Agents / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use; D000077404:Cidofovir; D002986:Clinical Trials as Topic; D003586:Cytomegalovirus Infections / Q000188:drug therapy / Q000821:virology; D003596:Cytosine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000737:chemistry / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology* / Q000627:therapeutic use
D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D003596:Cytosine; D000077404:Cidofovir